Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression
- 1Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. eva.schernhammer@channing.harvard.edu
- 0Department of Medicine, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. eva.schernhammer@channing.harvard.edu
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Low folate and vitamin B6 intake increases colorectal cancer risk, particularly for p53-overexpressing tumors. Higher intake of these nutrients is associated with a reduced risk of these specific cancer types.
Area Of Science
- Oncology
- Nutritional Science
- Molecular Biology
Background
- A low-folate diet is linked to increased colorectal cancer risk.
- Folate supplementation's role in adenoma recurrence is uncertain.
- Folate deficiency may induce p53 mutations in laboratory models.
Purpose Of The Study
- To investigate the association between folate and one-carbon nutrient intake and colorectal cancer risk.
- To examine the relationship between nutrient intake and tumor p53 expression.
- To determine if folate's effect on cancer risk differs based on p53 mutation status.
Main Methods
- Immunohistochemical assay of p53 expression in 399 colon cancer specimens.
- Analysis of a large prospective cohort of women with 22 years of follow-up.
- Assessment of folate and vitamin B6 intake in relation to tumor p53 expression and cancer risk.
Main Results
- Folate intake significantly modified the risk of p53-overexpressing (mutated) colorectal cancers (P(heterogeneity) = .01).
- Higher folate intake (≥200 microg/day) was associated with reduced risk of p53-overexpressing cancers, with relative risks ranging from 0.42 to 0.54.
- Folate intake did not influence the risk of wild-type tumors (RR, 1.05 for ≥400 vs <200 microg/day).
- High vitamin B6 intake also showed a protective effect against p53-overexpressing cancers (RR, 0.57) but not wild-type tumors.
Conclusions
- Low intake of folate and vitamin B6 is associated with an increased risk of p53-overexpressing colon cancers.
- The findings highlight a differential effect of folate and vitamin B6 based on tumor p53 expression status.
- These nutrients may play a role in the development of specific subtypes of colorectal cancer.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

